-+ 0.00%
-+ 0.00%
-+ 0.00%

Zejing Pharmaceutical announced that on August 12, 2026, the company re-submitted an application for the issuance of H shares to the Hong Kong Stock Exchange and listing on the main board of the Hong Kong Stock Exchange, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day. This application is a draft version, and the information contained in it may be updated and revised in due course. The listing is still subject to filing, approval or approval from relevant agencies such as the China Securities Regulatory Commission, the Hong Kong Securities Regulatory Commission, and the Hong Kong Stock Exchange. There is still uncertainty about this matter.

Zhitongcaijing·08/13/2026 08:17:04
Listen to the news
Zejing Pharmaceutical announced that on August 12, 2026, the company re-submitted an application for the issuance of H shares to the Hong Kong Stock Exchange and listing on the main board of the Hong Kong Stock Exchange, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day. This application is a draft version, and the information contained in it may be updated and revised in due course. The listing is still subject to filing, approval or approval from relevant agencies such as the China Securities Regulatory Commission, the Hong Kong Securities Regulatory Commission, and the Hong Kong Stock Exchange. There is still uncertainty about this matter.